Y. Ren et al. / Tetrahedron Letters 52 (2011) 192–195
195
Santagati, M.; Scolaro, L. Monsu; Russo, F. Eur. J. Med. Chem. 1997, 32, 973; (e)
Santagati, N. A.; Caruso, A.; Cutuli, V. M. C.; Caccamo, F. Farmaco 1995, 50, 689;
(f) Monge, A.; Martinez-Crespo, F. J.; Aranzazu Villanueva, M.; Font, M.;
Santiageo, E.; Martinez de Irujo, J. J.; Alberdi, E.; Lopez-Unzu, M. J.;
Cenarruzabeitia, E. Arch. Pharm. 1993, 326, 879; (g) Russo, F.; Romeo, G.;
Guccione, S.; De Blasi, A. J. Med. Chem. 1991, 34, 1850.
Supplementary data
Supplementary data associated with this article can be found, in
9. (a) Sabitha, G.; Kumar Reddy, G. S. K.; Reddy, Ch. S.; Yadav, J. S. Synlett 2003,
858; (b) Ryabukhin, S. V.; Plaskon, A. S.; Ostapchuk, E. N.; Volochnyuk, D. M.;
Tolmachev, A. A. Synthesis 2007, 417.
References and notes
10. General procedure for the photochemical reactions: to 40 mL DMSO was added
2.0 mmol 1a. The solution was distributed into two 25 mL Pyrex tubes and
1. (a) Moses, J. E.; Moorhouse, A. D. Chem. Soc. Rev. 2007, 36, 1249; (b) Gritsan, N.
P.; Platz, M. S. Chem. Rev. 2006, 106, 3844; (c) Braese, S.; Gil, C.; Knepper, K.;
Zimmermann, V. Angew. Chem., Int. Ed. 2005, 44, 5188; (d) Scriven, E. F.;
Turnbull, V. K. Chem. Rev. 1988, 88, 297.
2. (a) Minozzi, M.; Nanni, D.; Spagnolo, P. Chem. Eur. J. 2009, 15, 7830; (b) Lang, S.;
Murphy, J. A. Chem. Soc. Rev. 2005, 35, 146; (c)Organic Azides: Syntheses and
Applications; Bräse, S., Banert, K., Eds.; John Wiley and Sons Ltd: West Sussex,
UK, 2001; (d) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001,
40, 2004.
3. (a)Azides and Nitrenes—Reactivity and Utility; Scriven, E. F. V., Ed.; Academic
Press: New York, 1984; (b)The Chemistry of Halides, Pseudo—Halides and Azides,
Part 1and 2; Patai, S., Ed.; John Wiley and Sons, Ltd: Chichester, 1995.
4. Bayley, H. Photogenerated Reagents in Biochemistry and Molecular Biology;
Elsevier: New York, 1983; (b) Wang, J. F.; Downs, W. D.; Cech, T. R. Science
1993, 260, 504.
5. (a) Condie, G. C.; Channon, M. F.; Ivory, A. J.; Kumar, N.; Black, StC. D.
Tetrahedron 2005, 61, 4989; (b) Fresneda, P. M.; Molina, P. J.; Bleda, A.
Tetrahedron 2001, 57, 2355; (c) Pelkey, E. T.; Gribble, G. W. Tetrahedron Lett.
1997, 38, 5603; (d) Fresneda, P. M.; Molina, P. S.; Angeles Saez, M. Synlett 1999,
1651; (e) Kaszynski, P.; Dougherty, D. A. J. Org. Chem. 1993, 58, 5209; (f) Smith,
P. A. S.; Rowe, C. D.; Hansen, D. W. Tetrahedron Lett. 1983, 24, 5169; (g) Garanti,
L.; Zecchi, G. J. Org. Chem. 1980, 45, 4767; (h) Gairns, R. S.; Moody, C. J.; Rees, C.
W. J. Chem. Soc., Perkin Trans. 1 1986, 501.
6. (a) Morimoto, Y.; Matsuda, F.; Shimhama, H. Tetrahedron 1996, 52, 10609; (b)
Morimoto, Y.; Matsuda, F.; Shirahama, H. Tetrahedron Lett. 1990, 31, 6031.
7. Shi, Z.; Ren, Y.; Li, B.; Lu, S.; Zhang, W. Chem. Commun 2010, 46, 3973.
8. (a) Giuseppe, R.; Luisa, M.; Gabriella, M.; Maria, M.; Valeria, P.; Loredana, S.;
Angela, S. M.; Michela, B.; Piero, A.; Kenneth, P. M. Bioorg. Med. Chem. Lett. 2006,
16, 6200; (b) Giuseppe, R.; Luisa, M.; Fabrizio, M.; Alfredo, C.; Tiziana, M.;
Ferdinando, N.; Maurizio, B.; Filippo, R.; Kenneth, P. M. J. Med. Chem. 2003, 46,
2877; (c) Merino, I.; Monge, A.; Font, M.; Martinez de Irujo, J. J.; Alberdi, E.;
Santiago, E.; Prieto, I.; Lasarte, J. J.; Sarobe, P.; Borras, F. Farmaco 1999, 54, 255;
(d) Santagati, A.; Longmore, J.; Guccione, S.; Langer, T.; Tonnel, E.; Modica, M.;
irradiated with
a medium-pressure mercury lamp (500 W) at ambient
temperature for appropriate time. The progree of the reaction was monitored
by TLC at regular intervals. After 1a were disappeared, the solvent removed in
vacuo. The crude product was separated by silica gel column chromatography
eluted with hexane/acetone 5:1 (v/v) to afford 2a and further purified by
recrystallization from ethanol.
Ethyl 4-methylene-2-oxo-2,3,4,4a,5,9b-hexahydro-1H-pyrimido[5,4-b]indole-
4a-1carboxylate (2a): yellow solid; 1H NMR (400 MHz, DMSO-d6): d 1.95 (t, 3H,
J = 7.2 Hz), 4.16 (q, 2H, J = 7.2 Hz), 4.36 (d, 2H, J = 9.6 Hz), 4.89 (d, 1H,
J = 3.2 Hz), 6.61 (d, 1H, J = 8.0 Hz), 6.27–6.67 (t, 1H, J = 7.6 Hz), 6.79 (s, 1H),
7.02 (t, 1H, J = 7.6 Hz), 7.10 (d, 1H, J = 7.2 Hz), 7.49 (s, 1H), 8.97 (s, 1H); 13C NMR
(100.6 MHz, DMSO-d6): d 13.87, 57.4, 61.5, 67.3, 89.8, 109.3, 118.2, 123.7,
128.1, 128.8, 141.7, 148.1, 151.6, 170.8; LC–MS (ESI): m/z requires 273, found
([M+H+], 274); ESI-HRMS: m/z calcd for C14H15N3O3 + H+ (M+H+): 274.1186,
found: 274.1182.
1,3,5,6,7a,12b-Hexahydroquinazolino[9,4-b]indol-2,7-dione (2e) yellow solid;
1H NMR (400 MHz, DMSO-d6): d 2.24–2.31 (m, 1H), 2.32–2.42 (m, 1H), 2.53–
2.61 (m, 1H), 3.14–3.21 (m, 1H), 4.94 (s, 1H), 5.27 (t, 1H, J = 4.4 Hz), 6.48 (d, 1H,
J = 7.6 Hz), 6.63 (t, 1H, J = 7.6 Hz), 7.10 (d, 1H, J = 7.2 Hz), 7.62 (s, 1H), 9.00 (s,
1H); 13C NMR (100.6 MHz, DMSO-d6): d 25.4, 56.3, 72.4, 90.0, 109.36, 118.3,
123.5, 128.5, 128.6, 141.9, 147.9, 151.6, 204.4; LC–MS (ESI): m/z requires 255,
found ([M+H+], 256); ESI-HRMS: m/z calcd for C14H13N3O2 + H+ (M+H+):
256.1081, found: 256.1076.
11. Crystal data for compound 2b (recrystallized from ethanol).
Mr = 243.26. Orthorhombic, a = 7.3985(16) Å, b = 11.859(3) Å, c = 26.749(6) Å,
b = 90.00, V = 2346.9(9) Å3, yellow plates, = 1.377 g cmÀ3, T = 296(2) K, space
group P2 (1)/c, Z = 4, 2hmax = 51.0°, 17008
(Mo K ) = 0.71073 mmÀ1
C13H13N3O2,
q
l
,
a
reflections measured, 4349 unique (Rint = 0.0757) which were used in all
calculation. The final wR(F2) was 0.1543 (for all data), R1 = 0.0676. CCDC file no.
776808.